Literature DB >> 34633485

The future of antimicrobial dosing in the ICU: an opportunity for data science.

Thomas De Corte1,2, Paul Elbers3, Jan De Waele4,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34633485     DOI： 10.1007/s00134-021-06549-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  14 in total

1.  An Evolutionary Search Algorithm for Covariate Models in Population Pharmacokinetic Analysis.

Authors:  Fumiyoshi Yamashita; Atsuto Fujita; Yukako Sasa; Yuriko Higuchi; Masahiro Tsuda; Mitsuru Hashida
Journal:  J Pharm Sci       Date:  2017-04-25       Impact factor: 3.534

2.  LRRK2 Inhibition Ameliorates Dexamethasone-Induced Glucose Intolerance via Prevents Impairment in GLUT4 Membrane Translocation in Adipocytes.

Authors:  Motoki Imai; Fumitaka Kawakami; Makoto Kubo; Makoto Kanzaki; Hiroko Maruyama; Rei Kawashima; Tatsunori Maekawa; Yoshifumi Kurosaki; Fumiaki Kojima; Takafumi Ichikawa
Journal:  Biol Pharm Bull       Date:  2020       Impact factor: 2.233

3.  Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists.

Authors:  Michael J Rybak; Jennifer Le; Thomas P Lodise; Donald P Levine; John S Bradley; Catherine Liu; Bruce A Mueller; Manjunath P Pai; Annie Wong-Beringer; John C Rotschafer; Keith A Rodvold; Holly D Maples; Benjamin Lomaestro
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

4.  Prediction of vancomycin dose on high-dimensional data using machine learning techniques.

Authors:  Xiaohui Huang; Ze Yu; Xin Wei; Junfeng Shi; Yu Wang; Zeyuan Wang; Jihui Chen; Shuhong Bu; Lixia Li; Fei Gao; Jian Zhang; Ajing Xu
Journal:  Expert Rev Clin Pharmacol       Date:  2021-04-09       Impact factor: 5.045

5.  Therapeutic drug monitoring-based dose optimisation of piperacillin/tazobactam to improve outcome in patients with sepsis (TARGET): a prospective, multi-centre, randomised controlled trial.

Authors:  Stefan Hagel; Sandra Fiedler; Andreas Hohn; Alexander Brinkmann; Otto R Frey; Heike Hoyer; Peter Schlattmann; Michael Kiehntopf; Jason A Roberts; Mathias W Pletz
Journal:  Trials       Date:  2019-06-06       Impact factor: 2.279

6.  Right Dose Right Now: bedside data-driven personalized antibiotic dosing in severe sepsis and septic shock - rationale and design of a multicenter randomized controlled superiority trial.

Authors:  Luca F Roggeveen; Lucas M Fleuren; Tingjie Guo; Patrick Thoral; Harm Jan de Grooth; Eleonora L Swart; Thomas L T Klausch; Peter H J van der Voort; Armand R J Girbes; Rob J Bosman; Paul W G Elbers
Journal:  Trials       Date:  2019-12-18       Impact factor: 2.279

7.  Neurological manifestations associated with COVID-19: a multicentric registry.

Authors:  Elodie Meppiel; Nathan Peiffer-Smadja; Alexandra Maury; Imen Bekri; Cécile Delorme; Virginie Desestret; Lucas Gorza; Geoffroy Hautecloque-Raysz; Sophie Landre; Annie Lannuzel; Solène Moulin; Peggy Perrin; Paul Petitgas; François Sellal; Adrien Wang; Pierre Tattevin; Thomas de Broucker
Journal:  Clin Microbiol Infect       Date:  2020-11-12       Impact factor: 8.067

8.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

Review 9.  Artificial Intelligence in the Intensive Care Unit.

Authors:  Guillermo Gutierrez
Journal:  Crit Care       Date:  2020-03-24       Impact factor: 9.097

10.  The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.

Authors:  A Abdulla; T M J Ewoldt; N G M Hunfeld; A E Muller; W J R Rietdijk; S Polinder; T van Gelder; H Endeman; B C P Koch
Journal:  BMC Infect Dis       Date:  2020-01-17       Impact factor: 3.090
View more
  2 in total

1.  Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients.

Authors:  Jarne Verhaeghe; Sofie A M Dhaese; Thomas De Corte; David Vander Mijnsbrugge; Heleen Aardema; Jan G Zijlstra; Alain G Verstraete; Veronique Stove; Pieter Colin; Femke Ongenae; Jan J De Waele; Sofie Van Hoecke
Journal:  BMC Med Inform Decis Mak       Date:  2022-08-25       Impact factor: 3.298

2.  Right dose, right now: bedside, real-time, data-driven, and personalised antibiotic dosing in critically ill patients with sepsis or septic shock-a two-centre randomised clinical trial.

Authors:  Luca F Roggeveen; Tingjie Guo; Lucas M Fleuren; Ronald Driessen; Patrick Thoral; Reinier M van Hest; Ron A A Mathot; Eleonora L Swart; Harm-Jan de Grooth; Bas van den Bogaard; Armand R J Girbes; Rob J Bosman; Paul W G Elbers
Journal:  Crit Care       Date:  2022-09-05       Impact factor: 19.334
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.